Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
British Journal of Pharmacology|September 1, 1979
Relaxation of isolated taenia coli of guinea-pig by enantiomers of 2-azido analogues of adenosine and adenine nucleotidesN J Cusack, M Planker
Pathology, Research and Practice|November 1, 1980
The role of calcium in liver cell damage. Comparative studies with carbon tetrachloride and D-galactosamineH Kröner, M Planker
International Journal of Microcirculation, Clinical and Experimental|January 1, 1982
Evidence for the participation of superoxide anion radical in altering the adhesive interaction between granulocytes and endothelium, in vivoR F Del Maestro, M Planker, K E Arfors
Hepato-Gastroenterology|June 1, 1984
Synchronous double primary malignant lymphoma of low grade malignancy and early cancer (collision tumor) of the stomachM Planker, J T Fischer, U Peters, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 1985
[Role of computed tomography in extrapulmonary tuberculosis]M Planker, W D Schoppe, R M Jungblut, et al.
Acta Physiologica Scandinavica. Supplementum|January 1, 1980
Free radicals as mediators of tissue injuryR Del Maestro, H H Thaw, J Björk, et al.
Onkologie|February 1, 1987
High-dose cytosine arabinoside and mitoxantrone (HAM) for the treatment of refractory acute lymphoblastic leukemiaW Hiddemann, H Kreutzmann, R Donhuijsen-Ant, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemiaW Hiddemann, H Kreutzmann, K Straif, et al.
Leukemia|September 1, 1990
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM)W Hiddemann, T Büchner, G Heil, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG)D Peest, H Deicher, W Fett, et al.
Pageof 2